Autopsy report · NCT04718467

Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

“Sponsor decided to cancel this trial.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Jiangsu Province Centers for Disease Control and Prevention

Sponsor type

University, hospital or other

Conditions

COVID-19

Interventions

Recombinant COVID-19 vaccine (Sf9 cells); Placebo

Participants

0

Sites

1

Countries

China

Trials that died the same way

• A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
  “Trial was cancelled by Sponsor” (90% match in meaning)
• Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
  “Trial terminated by Sponsor.” (85% match in meaning)
• A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
  “Decision was made by Sponsor to stop the trial.” (84% match in meaning)
• Observational Study to Assess Migraine Prediction Tool
  “The Sponsor decided to cancel the study due to commercial considerations” (82% match in meaning)
• A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
  “Sponsor decision to cancel trial, not related to safety concern.” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.